Radiation treatment after surgery for breast cancer significantly lowers the risk that the disease will recur in the breast or spread lethally to other parts of the body over the next 10 to 15 years, researchers say.
Researchers at Wake Forest Baptist Medical Center have made a discovery that brings them one step closer to being able to better predict which patients have the best chance of surviving breast cancer.
Women with a deleterious gene mutation are diagnosed with breast cancer almost eight years earlier than relatives of the previous generation who also had the disease and/or ovarian cancer, according to new research from The University of Texas MD Anderson Cancer Center.
Women with low vitamin D levels may have an increased risk for the most aggressive breast cancers, new research suggests.
Healthy epithelial cells in breast tissue secrete an anticancer protein called interleukin 25 (IL25) that instructs malignant cells to self-destruct, leaving healthy cells intact, according to new research from the US published online this week in the journal Science Translational Medicine. The researchers hope their discovery provides a new target for drug development.